Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Exogenous Ketone Esters for Refractory Status Epileptics — Stella

Home/Status Epilepticus/Exogenous Ketone Esters for Refractory Status Epileptics

View on ClinicalTrials.gov

Recruiting

Back to Status Epilepticus trials

Exogenous Ketone Esters for Refractory Status Epileptics

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Egypt

Department of Pediatrics at Sohag University Hospital, Sohag

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Sohag University

Enrollment target

~50 participants

Started

January 2023

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

1 Year – 10 Years

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.